The Swedish-based medicinal company Oncorena has raised SEK 14.5m from its current shareholders P.U.L.S and HealthCap to prepare a clinical study of advanced kidney cancer. P.U.L.S is a Swedish life Science company and HealthCap is a Swedish VC firm. The stake size of the capital raise is not disclosed.
